Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice

Bone

Volumn 48, Issue 2, 2011, Pages 275-280

  Blazek, Joshua D ^a,b   Gaddy, Anna ^a,b   Meyer, Rachel ^a,b   Roper, Randall J ^a,b   Li, Jiliang ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone homeostasis; Down syndrome; Genetics; Mouse models; Trisomy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE METABOLISM; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; DENTIN; DOWN SYNDROME; FEMALE; FEMUR; INCISOR; MALE; MANDIBLE; MOUSE; NONHUMAN; OSSIFICATION; PATHOGENESIS; SKULL; TRABECULAR BONE; TRISOMY;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE DENSITY; DOWN SYNDROME; FEMALE; FEMUR; MICE; SKULL; TRISOMY;

EID: 78650997057     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.09.028     Document Type: Article

References (43)

1. Schieve L.A., Boulet S.L., Boyle C., Rasmussen S.A., Schendel D. Health of children 3 to 17years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics 2009, 123:e253-e260.
2. Cleves M.A., Hobbs C.A., Cleves P.A., Tilford J.M., Bird T.M., Robbins J.M. Congenital defects among liveborn infants with Down syndrome. Birth Defects Res A Clin Mol Teratol 2007, 79:657-663.
3. Richtsmeier J.T., Zumwalt A., Carlson E.J., Epstein C.J., Reeves R.H. Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am J Med Genet 2002, 107:317-324.
4. Van Cleve S.N., Cohen W.I. Part I: Clinical practice guidelines for children with Down syndrome from birth to 12years. J Pediatr Health Care 2006, 20:47-54.
5. Van Cleve S.N., Cannon S., Cohen W.I. Part II: Clinical practice guidelines for adolescents and young adults with Down syndrome: 12 to 21years. J Pediatr Health Care 2006, 20:198-205.
6. Richtsmeier J.T., Baxter L.L., Reeves R.H. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn 2000, 217:137-145.
7. Alio J.J., Lorenzo J., Iglesias C. Cranial base growth in patients with Down syndrome: a longitudinal study. Am J Orthod Dentofacial Orthop 2008, 133:729-737.
8. de Moraes M.E., Tanaka J.L., de Moraes L.C., Filho E.M., de Melo Castilho J.C. Skeletal age of individuals with Down syndrome. Spec Care Dentist 2008, 28:101-106.
9. Keeling J.W., Hansen B.F., Kjaer I. Pattern of malformations in the axial skeleton in human trisomy 21 fetuses. Am J Med Genet 1997, 68:466-471.
10. Longo D., DeFigueiredo D., Cicero S., Sacchini C., Nicolaides K.H. Femur and humerus length in trisomy 21 fetuses at 11-14weeks of gestation. Ultrasound Obstet Gynecol 2004, 23:143-147.
11. Gray D.L., Dicke J.M., Dickerson R., McCourt C., Odibo A.O. Reevaluating humeral length for the detection of fetal trisomy 21. J Ultrasound Med 2009, 28:1325-1330.
12. Weisz B., David A.L., Chitty L., Peebles D., Pandya P., Patel P., et al. Association of isolated short femur in the mid-trimester fetus with perinatal outcome. Ultrasound Obstet Gynecol 2008, 31:512-516.
13. Guijarro M., Valero C., Paule B., Gonzalez-Macias J., Riancho J.A. Bone mass in young adults with Down syndrome. J Intellect Disabil Res 2008, 52:182-189.
14. Baptista F., Varela A., Sardinha L.B. Bone mineral mass in males and females with and without Down syndrome. Osteoporos Int 2005, 16:380-388.
15. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., et al. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 1995, 11:177-184.
16. Hattori M., Fujiyama A., Sakaki Y. The DNA sequence of human chromosome 21. Tanpakushitsu Kakusan Koso 2001, 46:2254-2261.
17. Gardiner K., Fortna A., Bechtel L., Davisson M.T. Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. Gene 2003, 318:137-147.
18. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 1996, 93:13333-13338.
19. Moore C.S., Roper R.J. The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome 2007, 18:431-443.
20. Wiseman F.K., Alford K.A., Tybulewicz V.L., Fisher E.M. Down syndrome-recent progress and future prospects. Hum Mol Genet 2009, 18:R75-R83.
21. Hill C.A., Reeves R.H., Richtsmeier J.T. Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat 2007, 210:394-405.
22. Baxter L.L., Moran T.H., Richtsmeier J.T., Troncoso J., Reeves R.H. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 2000, 9:195-202.
23. Li J., Meyer R., Duncan R.L., Turner C.H. P2X7 nucleotide receptor plays an important role in callus remodeling during fracture repair. Calcif Tissue Int 2009, 84:405-412.
24. McCarthy E.A., Raggio C.L., Hossack M.D., Miller E.A., Jain S., Boskey A.L., et al. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model. Pediatr Res 2002, 52:660-670.
25. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608.
26. Allen M.R., Reinwald S., Burr D.B. Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3years of daily treatment. Calcif Tissue Int 2008, 82:354-360.
27. Kohler T., Beyeler M., Webster D., Muller R. Compartmental bone morphometry in the mouse femur: reproducibility and resolution dependence of microtomographic measurements. Calcif Tissue Int 2005, 77:281-290.
28. Masinde G.L., Li X., Gu W., Wergedal J., Mohan S., Baylink D.J. Quantitative trait loci for bone density in mice: the genes determining total skeletal density and femur density show little overlap in F2 mice. Calcif Tissue Int 2002, 71:421-428.
29. Parsons T., Ryan T.M., Reeves R.H., Richtsmeier J.T. Microstructure of trabecular bone in a mouse model for Down syndrome. Anat Rec (Hoboken) 2007, 290:414-421.
30. Burr D.B. Bone material properties and mineral matrix contributions to fracture risk or age in women and men. J Musculoskelet Neuronal Interact 2002, 2:201-204.
31. Viguet-Carrin S., Garnero P., Delmas P.D. The role of collagen in bone strength. Osteoporos Int 2006, 17:319-336.
32. Stewart L.S., Persinger M.A., Cortez M.A., Snead O.C. Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome. Behav Genet 2007, 37:388-398.
33. Escorihuela R.M., Fernandez-Teruel A., Vallina I.F., Baamonde C., Lumbreras M.A., Dierssen M., et al. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci Lett 1995, 199:143-146.
34. Mitsiadis T.A., Graf D. Cell fate determination during tooth development and regeneration. Birth Defects Res C Embryo Today 2009, 87:199-211.
35. Gitton Y., Heude E., Vieux-Rochas M., Benouaiche L., Fontaine A., Sato T., et al. Evolving maps in craniofacial development. Semin Cell Dev Biol 2010, 21:301-308.
36. Roper R.J., VanHorn J.F., Cain C.C., Reeves R.H. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 2009, 126:212-219.
37. Gitton Y., Dahmane N., Baik S., Ruiz i Altaba A., Neidhardt L., Scholze M., et al. A gene expression map of human chromosome 21 orthologues in the mouse. Nature 2002, 420:586-590.
38. Arron J.R., Winslow M.M., Polleri A., Chang C.P., Wu H., Gao X., et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006, 441:595-600.
39. Lee Y., Ha J., Kim H.J., Kim Y.S., Chang E.J., Song W.J., et al. Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J Biol Chem 2009, 284:33343-33351.
40. Brown R., Taylor J., Matthews B. Quality of life-ageing and Down syndrome. Downs Syndr Res Pract 2001, 6:111-116.
41. Hawli Y., Nasrallah M., El-Hajj Fuleihan G. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 2009, 5:327-334.
42. Center J., Beange H., McElduff A. People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard 1998, 103:19-28.
43. Moore C.S., Lee J.S., Birren B., Stetten G., Baxter L.L., Reeves R.H. Integration of cytogenetic with recombinational and physical maps of mouse chromosome 16. Genomics 1999, 59:1-5.